Antibody data
- Antibody Data
- Antigen structure
- References [4]
- Comments [0]
- Validations
- Western blot [1]
Submit
Validation data
Reference
Comment
Report error
- Product number
- ABIN2840161 - Provider product page
- Provider
- antibodies-online
- Product name
- anti-Sema Domain, Immunoglobulin Domain (Ig), Short Basic Domain, Secreted, (Semaphorin) 3C (SEMA3C) (AA 592-620), (C-Term) antibody
- Antibody type
- Polyclonal
- Description
- This antibody is purified through a protein A column, followed by peptide affinity purification.
- Reactivity
- Human, Mouse
- Host
- Rabbit
- Epitope
- AA 592-620, C-Term
- Antibody clone number
- RB22998
- Vial size
- 80 μL
- Storage
- Maintain refrigerated at 2-8°C for up to 6 months. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.
Submitted references High level of Sema3C is associated with glioma malignancy.
The cleavage of semaphorin 3C induced by ADAMTS1 promotes cell migration.
Genome-wide association meta-analysis for total serum bilirubin levels.
GATA6 mutations cause human cardiac outflow tract defects by disrupting semaphorin-plexin signaling.
Vaitkienė P, Skiriutė D, Steponaitis G, Skauminas K, Tamašauskas A, Kazlauskas A
Diagnostic pathology 2015 Jun 2;10:58
Diagnostic pathology 2015 Jun 2;10:58
The cleavage of semaphorin 3C induced by ADAMTS1 promotes cell migration.
Esselens C, Malapeira J, Colomé N, Casal C, Rodríguez-Manzaneque JC, Canals F, Arribas J
The Journal of biological chemistry 2010 Jan 22;285(4):2463-73
The Journal of biological chemistry 2010 Jan 22;285(4):2463-73
Genome-wide association meta-analysis for total serum bilirubin levels.
Johnson AD, Kavousi M, Smith AV, Chen MH, Dehghan A, Aspelund T, Lin JP, van Duijn CM, Harris TB, Cupples LA, Uitterlinden AG, Launer L, Hofman A, Rivadeneira F, Stricker B, Yang Q, O'Donnell CJ, Gudnason V, Witteman JC
Human molecular genetics 2009 Jul 15;18(14):2700-10
Human molecular genetics 2009 Jul 15;18(14):2700-10
GATA6 mutations cause human cardiac outflow tract defects by disrupting semaphorin-plexin signaling.
Kodo K, Nishizawa T, Furutani M, Arai S, Yamamura E, Joo K, Takahashi T, Matsuoka R, Yamagishi H
Proceedings of the National Academy of Sciences of the United States of America 2009 Aug 18;106(33):13933-8
Proceedings of the National Academy of Sciences of the United States of America 2009 Aug 18;106(33):13933-8
No comments: Submit comment
Supportive validation
- Submitted by
- antibodies-online (provider)
- Main image
- Experimental details
- WB